Plain-English translation of NCT06429813 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether two different home-based exercise programs—high-intensity cycling or walking—can help improve fitness and muscle strength in men with metastatic castrate-sensitive prostate cancer who are being treated with hormone therapy drugs like leuprolide, degarelix, abiraterone, enzalutamide, apalutamide, or darolutamide. The researchers want to see if regular exercise reduces cancer-related fatigue and improves how patients feel during their treatment.
Cancer treatment can cause fatigue and weakness that significantly affects quality of life. This study explores whether supervised home-based exercise can help men stay stronger and have more energy while undergoing hormone therapy for advanced prostate cancer.
You likely qualify if…
You likely don't qualify if…
You will attend one or two training sessions at the research lab to learn your exercise program and set up monitoring devices (an activity watch and heart rate chest strap). You will be randomly assigned to either a high-intensity stationary cycling program or a walking program, with a personalized plan to gradually build up to your exercise goal. For the next 12 weeks, you will exercise at home while the research team monitors your progress remotely using your activity watch and heart rate data. The study team will check in with you regularly to answer questions and track how you're feeling.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States